Equities

Laboratorios Farmaceuticos ROVI SA

Laboratorios Farmaceuticos ROVI SA

Actions
  • Price (EUR)27.30
  • Today's Change-0.20 / -0.73%
  • Shares traded18.16k
  • 1 Year change26.98%
  • Beta0.2003
Data delayed at least 15 minutes, as of Aug 10 2020 16:35 BST.
More ▼

Events & Activity

  • ROVI:MCE price moved over +2.13% to 28.80

Key statistics

On Monday, Laboratorios Farmaceuticos ROVI SA (ROVI:MCE) closed at 27.30, -19.23% below its 52-week high of 33.80, set on Jul 20, 2020.
52-week range
Today
19.85Sep 18 201933.80Jul 20 2020
Markit short selling activity
Low
Med
High
Open27.90
High27.90
Low27.20
Bid27.20
Offer28.00
Previous close27.50
Average volume55.50k
Shares outstanding56.07m
Free float17.84m
P/E (TTM)28.83
Market cap1.54bn EUR
EPS (TTM)0.9539
EUR
Annual div (ADY)--
Annual div yield (ADY)0.29%
Div ex-dateJul 02 2019
Div pay-dateJul 04 2019
Data delayed at least 15 minutes, as of Aug 10 2020 16:35 BST.
More ▼
The Financial and Risk business of Thomson Reuters is now Refinitiv
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.